Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heated tobacco: how do smokers really puff?

NCT ID NCT07175987

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study in the UK observed 212 cigarette smokers to see how they use heated tobacco products. Participants puffed on devices in a lab setting, and a smaller group used the products at home for 5 days. The goal was to measure puffing patterns and daily consumption, not to test health effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
heated tobacco products (HTP devices and sticks)
What this could lead to
If successful, this study could help regulators and companies understand how smokers actually use heated tobacco products, potentially informing harm reduction strategies.
What could go wrong
This is an observational consumer use study, not a clinical trial testing safety or health effects. Results may not reflect long-term use or health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

212 people

The number who actually took part.

Started

Sep 2025

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be aged 21-65 years (inclusive) * Be self-reported current 'daily users' of at least 5 CPD and have smoked at least 100 cigarettes in their lifetime. ('daily users' defined as have smoked 5 CPD for at least 27 days out of last 30 days) * Agree to participate in the study and to abide by the study restrictions and requirements, including the use of the assigned Study IP, as described in the ICF. * Agree not to allow any other person to use any product provided to them for use during this study. Exclusion Criteria: * Women who self-report they are pregnant or breastfeeding or could become pregnant or start breastfeeding in the next three months from the study start date. * Women who self-report they are not using adequate methods to prevent pregnancy, which they intend to continue throughout the study. a. Examples of acceptable means of birth control are, but not limited to: i. Surgical sterilization (hysterectomy, bilateral tubal litigation/occlusion, bilateral oophorectomy, bilateral salpingectomy); ii. Established use of oral, implantable, injectable, or transdermal methods of contraception associated with inhibition of ovulation; iii. Physical barrier method (e.g., condom, diaphragm/sponge/cervical cap) with spermicide; iv. Non-hormone releasing intrauterine devices (IUD) or hormone-releasing IUDs (e.g., Mirena or Kyleena); v. Vasectomized partner; vi. Abstinence from heterosexual intercourse (as a lifestyle choice, not just for the purpose of study participation; and vii. Post-menopausal and not on hormone replacement Therapy * People who self- report having pacemakers or other embedded electronic medical devices. * People who self-report having heart disease, high blood pressure, diabetes, depression, or asthma. * People who have ever used HTP. * People who self-report currently quitting or planning to quit all nicotine products in the next 3 months. * People who self-report having participated in tobacco product research in the past 3 months. * People who self-report themselves, or someone in their direct family or close friends, as working in one of the following areas: 1. Advertising 2. Journalism 3. Media 4. Insurance 5. Marketing 6. Market Research 7. Manufacturer or retailer of tobacco or vapor products 8. Public Relations 9. Sale of Alcohol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smoking ( cigarette) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cigarette Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Channing Hall

    Sheffield, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.